Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

"Questionable results" yielded by feline diabetes research
cat
Dr Niessen says human-style clinical trials are needed to compare the effectiveness of different treatments.
RVC's systematic review finds more collaboration and larger sample sizes are needed

Past research on feline diabetes lacks collaboration and is based on low-level evidence, leading to "questionable results". This is according to a systematic review of research papers carried out by the Royal Veterinary College (RVC).

"Current research into the condition is sporadic, lacking a long-term vision and not collaborative," says Dr Stijn Niessan, who launched the RVC's Feline Diabetic Remission Clinic (FDRC) with his team in 2013.

Dr Niessan believes human-style clinical trials are the best method to compare remission rates with different types of insulin.

"The only way to improve the quality of research and its results is to design and implement well-structured clinical trials, similar to those used by pharmaceutical companies in human medicine.

“This sort of trial can have a powerful impact on a treatment and how it is used. They can more accurately gauge the pros and cons of specific diabetic treatments for cats, helping us pinpoint troublesome side effects as well as identifying the benefits."

Researchers say treatment recommendations are based on past research with sample sizes of as few as eight cat and the largest samples contained 50 to 60 cats. Statistical tests carried out by the FDRC team suggest that a minimum of 80 to 90 cats are required to accurately compare different treatments.

Dr Niessan says more collaboration is needed both nationally and internationally to address the inconsistencies in the treatment of feline diabetes.

"A pet owner can, in theory, go to two different vets and get two very different treatments for the same condition," he explains. "The owner could then go online and find a third way. These treatments aren’t necessarily wrong, it is just one vet may have been trained in one methodology and another in a different way.

"This is why a collaborative approach is so important, so we can end these inconsistencies and can get closer to the actual truth about which way best to treat our feline friends."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.